Cytek Biosciences (CTKB) Earnings Date & Reports

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CTKB is expected to report earnings to fall 33.33% to -5 cents per share on November 11

Cytek Biosciences CTKB Stock Earnings Reports

Q3'26

Est.

$-0.06

Q2'26

Missed

by $0.01

Q1'26

Missed

by $0.05

Q4'25

Missed

by $0.32

Q3'25

Missed

by $0.01

The last earnings report on August 05 showed earnings per share of -9 cents, missing the estimate of -7 cents. With 452.38K shares outstanding, the current market capitalization sits at 625.22M.

View a ticker or compare two or three

CTKB

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days